Redmile Group as of March 31, 2020
Portfolio Holdings for Redmile Group
Redmile Group holds 69 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 7.0 | $249M | 11M | 22.21 | |
Amicus Therapeutics (FOLD) | 6.5 | $233M | 25M | 9.24 | |
Deciphera Pharmaceuticals (DCPH) | 5.9 | $211M | 5.1M | 41.17 | |
Biogen Idec (BIIB) | 5.2 | $186M | 589k | 316.38 | |
Igm Biosciences (IGMS) | 4.9 | $177M | 3.1M | 56.15 | |
Argenx Se (ARGX) | 4.0 | $143M | 1.1M | 131.73 | |
Momenta Pharmaceuticals | 3.9 | $141M | 5.2M | 27.20 | |
Epizyme | 3.8 | $136M | 8.8M | 15.51 | |
Principia Biopharma | 3.8 | $134M | 2.3M | 59.38 | |
Allakos (ALLK) | 3.7 | $132M | 3.0M | 44.49 | |
Uniqure Nv (QURE) | 3.7 | $132M | 2.8M | 47.45 | |
Aprea Therapeutics | 2.2 | $79M | 2.3M | 34.76 | |
Regenxbio Inc equity us cm (RGNX) | 2.1 | $76M | 2.3M | 32.38 | |
Seattle Genetics | 2.1 | $76M | 656k | 115.38 | |
Nevro (NVRO) | 2.0 | $71M | 706k | 99.98 | |
Merck & Co (MRK) | 1.7 | $61M | 789k | 76.94 | |
Beam Therapeutics (BEAM) | 1.7 | $61M | 3.4M | 18.00 | |
UnitedHealth (UNH) | 1.7 | $60M | 241k | 249.38 | |
ImmunoGen | 1.6 | $57M | 17M | 3.41 | |
Tandem Diabetes Care (TNDM) | 1.6 | $57M | 881k | 64.35 | |
1life Healthcare | 1.6 | $57M | 3.1M | 18.15 | |
Novartis (NVS) | 1.5 | $54M | 654k | 82.45 | |
Cigna Corp (CI) | 1.5 | $53M | 301k | 177.18 | |
Stoke Therapeutics (STOK) | 1.4 | $50M | 2.2M | 22.90 | |
Centene Corporation (CNC) | 1.4 | $49M | 824k | 59.41 | |
Tricida | 1.3 | $47M | 2.1M | 22.00 | |
Neoleukin Therapeutics | 1.3 | $46M | 4.0M | 11.38 | |
Krystal Biotech (KRYS) | 1.3 | $46M | 1.1M | 43.24 | |
Atara Biotherapeutics (ATRA) | 1.3 | $45M | 5.3M | 8.51 | |
Axonics Modulation Technolog (AXNX) | 1.1 | $38M | 1.5M | 25.41 | |
Pra Health Sciences | 1.0 | $37M | 443k | 83.04 | |
Scholar Rock Hldg Corp (SRRK) | 1.0 | $35M | 2.9M | 12.11 | |
Dex (DXCM) | 1.0 | $35M | 129k | 269.27 | |
Eidos Therapeutics | 0.9 | $34M | 690k | 48.99 | |
Genmab A/s -sp (GMAB) | 0.9 | $33M | 1.5M | 21.19 | |
Amedisys (AMED) | 0.9 | $33M | 178k | 183.54 | |
Cryoport Inc Com Par $0 001 (CYRX) | 0.9 | $31M | 1.8M | 17.07 | |
Zymeworks | 0.9 | $31M | 869k | 35.47 | |
Replimune Group (REPL) | 0.8 | $30M | 3.0M | 9.97 | |
Wave Life Sciences (WVE) | 0.8 | $27M | 2.9M | 9.37 | |
Catalent (CTLT) | 0.7 | $26M | 506k | 51.95 | |
Ppd | 0.6 | $23M | 1.3M | 17.81 | |
Ardelyx (ARDX) | 0.6 | $22M | 3.9M | 5.68 | |
Odonate Therapeutics Ord | 0.5 | $20M | 708k | 27.61 | |
Atreca Inc Cl A (BCEL) | 0.5 | $19M | 1.1M | 16.55 | |
Shockwave Med (SWAV) | 0.5 | $19M | 558k | 33.18 | |
Twist Bioscience Corp (TWST) | 0.5 | $18M | 590k | 30.58 | |
Gritstone Oncology Ord (GRTS) | 0.5 | $18M | 3.1M | 5.82 | |
Hookipa Pharma Inc equity (HOOK) | 0.4 | $15M | 1.9M | 8.25 | |
Tcr2 Therapeutics Inc cs | 0.4 | $14M | 1.8M | 7.74 | |
Akero Therapeutics (AKRO) | 0.3 | $12M | 570k | 21.20 | |
Adaptive Biotechnologies Cor (ADPT) | 0.3 | $12M | 414k | 27.78 | |
Cabaletta Bio (CABA) | 0.3 | $10M | 1.4M | 7.30 | |
Biontech Se (BNTX) | 0.3 | $9.9M | 170k | 58.40 | |
Stereotaxis (STXS) | 0.3 | $9.4M | 3.1M | 3.02 | |
Rts/bristol-myers Squibb Compa | 0.3 | $9.1M | 2.4M | 3.80 | |
Itamar Med | 0.2 | $7.4M | 625k | 11.78 | |
Revolution Medicines (RVMD) | 0.2 | $6.6M | 303k | 21.91 | |
Xeris Pharmaceuticals | 0.2 | $5.8M | 3.0M | 1.95 | |
Cymabay Therapeutics | 0.1 | $4.1M | 2.8M | 1.48 | |
Profound Med Corp (PROF) | 0.1 | $3.9M | 400k | 9.74 | |
Gossamer Bio (GOSS) | 0.1 | $2.6M | 260k | 10.15 | |
Syros Pharmaceuticals | 0.0 | $1.3M | 212k | 5.93 | |
Clovis Oncology | 0.0 | $633k | 100k | 6.36 | |
Glycomimetics (GLYC) | 0.0 | $578k | 254k | 2.28 | |
Vapotherm | 0.0 | $471k | 25k | 18.84 | |
Ovid Therapeutics (OVID) | 0.0 | $363k | 122k | 2.98 | |
Endologix | 0.0 | $54k | 79k | 0.69 | |
Castlight Health | 0.0 | $7.0k | 10k | 0.68 |